Pfizer's Quarterly Profit; Lipitor Patent Expires

Pfizer's Quarterly Profit; Lipitor Patent Expires Play

Nov. 1 (Bloomberg) -- Tony Butler, an analyst at Barclays Capital, talks about Pfizer Inc.'s third-quarter profit, share buyback program and the patent expiration of the company's Lipitor drug. Pfizer Inc., the world’s largest drugmaker, raised its annual forecast and reported a quarterly profit, excluding one-time items, 62 cents a share. Butler speaks on Bloomberg Television's "InBusiness with Margaret Brennan." (Source: Bloomberg)

  • On Air Now

    The Pulse Watch Now

  • Next

    Bloomberg Surveillance

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus